| Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome HJ Teede, CT Tay, JJE Laven, A Dokras, LJ Moran, TT Piltonen, ... European journal of endocrinology 189 (2), G43-G64, 2023 | 647 | 2023 |
| What is the pipeline for future medications for obesity? E Melson, U Ashraf, D Papamargaritis, MJ Davies International Journal of Obesity, 1-19, 2024 | 101 | 2024 |
| SIMBA: using Kolb’s learning theory in simulation-based learning to improve participants’ confidence M Davitadze, E Ooi, CY Ng, D Zhou, L Thomas, T Hanania, P Blaggan, ... BMC medical education 22 (1), 116, 2022 | 50 | 2022 |
| Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome P Kempegowda, E Melson, KN Manolopoulos, W Arlt, MW O’Reilly Therapeutic advances in endocrinology and metabolism 11, 2042018820934319, 2020 | 50 | 2020 |
| Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus? A Kyriacou, E Melson, W Chen, P Kempegowda Clinical Medicine 20 (4), 417-423, 2020 | 43 | 2020 |
| A systematic review of lived experiences of people with polycystic ovary syndrome highlights the need for holistic care and co-creation of educational resources GM Lau, M Elghobashy, M Thanki, S Ibegbulam, P Latthe, CDT Gillett, ... Frontiers in Endocrinology 13, 1064937, 2022 | 33 | 2022 |
| Clinical and biochemical profile of 786 sequential episodes of diabetic ketoacidosis in adults with type 1 and type 2 diabetes mellitus E Ooi, K Nash, L Rengarajan, E Melson, L Thomas, A Johnson, D Zhou, ... BMJ Open Diabetes Research and Care 9 (2), e002451, 2021 | 31 | 2021 |
| Effect of COVID-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes P Kempegowda, E Melson, A Johnson, L Wallett, L Thomas, D Zhou, ... Endocrine connections 10 (4), 371-377, 2021 | 29 | 2021 |
| Future therapies for obesity E Melson, AD Miras, D Papamargaritis Clinical Medicine 23 (4), 337-346, 2023 | 19 | 2023 |
| Simulation via instant messaging-Birmingham advance (SIMBA) model helped improve clinicians’ confidence to manage cases in diabetes and endocrinology E Melson, M Davitadze, M Aftab, CY Ng, E Ooi, P Blaggan, W Chen, ... BMC medical education 20, 1-10, 2020 | 18 | 2020 |
| Developing a simulation-based learning model for acute medical education during COVID-19 pandemic with simulation via instant Messaging–Birmingham advance (SIMBA) L Wallett, W Chen, L Thomas, P Blaggan, E Ooi, D Zhou, T Hanania, ... BMJ open quality 11 (2), e001565, 2022 | 17 | 2022 |
| Identifying the challenges and opportunities of PCOS awareness month by analysing its global digital impact K Malhotra, CSC Pan, M Davitadze, Team PCOS SEva, P Kempegowda Frontiers in Endocrinology 14, 1109141, 2023 | 13 | 2023 |
| Utility of simulation via instant messaging–Birmingham advance (SIMBA) in medical education during COVID-19 pandemic G Morgan, E Melson, M Davitadze, E Ooi, D Zhou, T Hanania, W Chen, ... Journal of the Royal College of Physicians of Edinburgh 51 (2), 168-172, 2021 | 12 | 2021 |
| A systematic review of models of care for polycystic ovary syndrome highlights the gap in the literature, especially in developing countries E Melson, M Davitadze, K Malhotra, PCOS SEva Working Group, ... Frontiers in Endocrinology 14, 1217468, 2023 | 11 | 2023 |
| Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now? P Gogineni, E Melson, D Papamargaritis, M Davies Expert Opinion on Pharmacotherapy, 2024 | 10 | 2024 |
| Interventions for the prevention of adrenal crisis in adults with primary adrenal insufficiency: a systematic review LM Shepherd, KA Schmidtke, JM Hazlehurst, E Melson, J Dretzke, ... European journal of endocrinology 187 (1), S1-S20, 2022 | 9 | 2022 |
| Myocardial Infarction with non-obstructed coronaries–atypical presentation of pheochromocytoma E Melson, S Amir, L Shepherd, S Kauser, B Freestone, P Kempegowda Endocrinology, diabetes & metabolism case reports 2019 (1), 2019 | 8 | 2019 |
| Differences in presentation, severity and management of DKA in type 1 and type 2 diabetes during the COVID-19 pandemic L Wallett, P Kempegowda, E Melson, A Juszczak, L Thomas, D Zhou, ... Clinical Medicine 21 (Suppl 2), 1-2, 2021 | 6 | 2021 |
| Diabetic myonecrosis: an uncommon diabetic complication P Kempegowda, E Melson, G Langman, F Khattar, M Karamat, QA Altaf Endocrinology, diabetes & metabolism case reports 2019 (1), 2019 | 6 | 2019 |
| Sex-Specific Obesity and Cardiometabolic Disease Risks in Low-and Middle-Income Countries: A Meta-Analysis Involving 3 916 276 Individuals T Rocha, E Melson, J Zamora, BM Fernandez-Felix, W Arlt, ... The Journal of Clinical Endocrinology & Metabolism 109 (4), 1145-1153, 2024 | 5 | 2024 |
